1 A Systematic Review of miR-29 in Cancer

被引:200
作者
Kwon, Jason J. [1 ]
Factora, Tricia D. [1 ]
Dey, Shatovisha [1 ]
Kota, Janaiah [1 ,2 ]
机构
[1] Indiana Univ Sch Med, Dept Med & Mol Genet, 975 West Walnut St,IB 244C, Indianapolis, IN 46202 USA
[2] IUSM, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA
关键词
ACUTE MYELOID-LEUKEMIA; SINGLE-STRANDED RNA; CELL LUNG-CANCER; MICRORNA-29; FAMILY; DNA METHYLTRANSFERASES; OVARIAN-CANCER; MESENCHYMAL TRANSITION; GENE-EXPRESSION; DOWN-REGULATION; BREAST-CANCER;
D O I
10.1016/j.omto.2018.12.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNA) are small non-coding RNAs (similar to 22 nt in length) that are known as potent master regulators of eukaryotic gene expression. miRNAs have been shown to play a critical role in cancer pathogenesis, and the misregulation of miRNAs is a well-known feature of cancer. In recent years, miR-29 has emerged as a critical miRNA in various cancers, and it has been shown to regulate multiple oncogenic processes, including epigenetics, proteostasis, metabolism, proliferation, apoptosis, metastasis, fibrosis, angiogenesis, and immunomodulation. Although miR-29 has been thoroughly documented as a tumor suppressor in the majority of studies, some controversy remains with conflicting reports of miR-29 as an oncogene. In this review, we provide a systematic overview of miR-29's functional role in various mechanisms of cancer and introspection on the contradictory roles of miR-29.
引用
收藏
页码:173 / 194
页数:22
相关论文
共 256 条
[21]   Tumor-associated stromal cells as key contributors to the tumor microenvironment [J].
Bussard, Karen M. ;
Mutkus, Lysette ;
Stumpf, Kristina ;
Gomez-Manzano, Candelaria ;
Marini, Frank C. .
BREAST CANCER RESEARCH, 2016, 18
[22]   Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients [J].
Butrym, Aleksandra ;
Rybka, Justyna ;
Baczynska, Dagmara ;
Poreba, Rafal ;
Kuliczkowski, Kazimierz ;
Mazur, Grzegorz .
ONCOTARGET, 2016, 7 (21) :30250-30257
[23]   Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].
Calin, GA ;
Dumitru, CD ;
Shimizu, M ;
Bichi, R ;
Zupo, S ;
Noch, E ;
Aldler, H ;
Rattan, S ;
Keating, M ;
Rai, K ;
Rassenti, L ;
Kipps, T ;
Negrini, M ;
Bullrich, F ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529
[24]   MiR-15a and miR-16-1 cluster functions in human leukemia [J].
Calin, George A. ;
Cimmino, Amelia ;
Fabbri, Muller ;
Ferracin, Manuela ;
Wojcik, Sylwia E. ;
Shimizu, Masayoshi ;
Taccioli, Cristian ;
Zanesi, Nicola ;
Garzon, Ramiro ;
Aqeilan, Rami I. ;
Alder, Hansjuerg ;
Volinia, Stefano ;
Rassenti, Laura ;
Liu, Xiuping ;
Liu, Chang-gong ;
Kipps, Thomas J. ;
Negrini, Massimo ;
Croce, Carlo M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (13) :5166-5171
[25]   The Polycomb EA2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation [J].
Caretti, G ;
Di Padova, M ;
Micales, B ;
Lyons, GE ;
Sartorelli, V .
GENES & DEVELOPMENT, 2004, 18 (21) :2627-2638
[26]   VEGF as a key mediator of angiogenesis in cancer [J].
Carmeliet, P .
ONCOLOGY, 2005, 69 :4-10
[27]   Cdc42: new roads to travel [J].
Cerione, RA .
TRENDS IN CELL BIOLOGY, 2004, 14 (03) :127-132
[28]   A Perspective on Cancer Cell Metastasis [J].
Chaffer, Christine L. ;
Weinberg, Robert A. .
SCIENCE, 2011, 331 (6024) :1559-1564
[29]   Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine [J].
Chakraborty, Chiranjib ;
Sharma, Ashish Ranjan ;
Sharma, Garima ;
Doss, C. George Priya ;
Lee, Sang-Soo .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 8 :132-143
[30]  
Chen Chang-fu, 2015, China Journal of Highway and Transport, V28, P1